A new AI diagnostic tool, named PROVIZ, developed by researchers at the Norwegian University of Science and Technology, aims to assist radiologists in analyzing prostate cancer scans more efficiently. This innovative system utilizes MRI images to help determine whether a biopsy is necessary and to identify optimal tissue sampling locations. Trials conducted at St Olav’s Hospital indicate that PROVIZ could significantly accelerate prostate cancer diagnoses, an essential advancement since prostate cancer is the most prevalent cancer among men in many Western nations. The rising use of PSA blood tests has increased the need for specialist MRI analysis. Patient feedback reveals strong support for AI-assisted diagnostics, provided medical professionals validate the findings. Experts emphasize that building trust in healthcare providers is crucial for the broader implementation of AI technologies. For insights into AI, technology, and digital diplomacy, engage with our Diplo chatbot for more information.
Source link
